ROYALTY PHARMA PLC- CL A (RPRX)
GB00BMVP7Y09 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 477.01M | 1.71B | 1.54B | 1.01B | 284.00M | |||
| Marketable Securities | 756.74M | 717.00M | 1.26B | 1.64B | 510.00M | |||
| Receivables | 36.65M | 37.00M | 68.00M | 39.00M | 39.00M | |||
| Other Current Assets | 3.80M | 91.00M | 7.00M | 9.00M | 0.00 | |||
| Total Current Assets | 1.27B | 2.56B | 2.88B | 2.70B | 832.00M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 15.10B | 14.23B | 14.63B | 13.27B | 11.48B | |||
| Intangibles | N/A | 0.00 | 6.00M | 29.00M | 52.00M | |||
| Other Non-Current Assets | 6.52M | 30.00M | 4.00M | 29.00M | 88.00M | |||
| Total Non-Current Assets | 15.11B | 14.26B | 14.64B | 13.32B | 11.62B | |||
| TOTAL ASSETS | 16.38B | 16.81B | 17.52B | 16.02B | 12.45B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 998.00M | N/A | 0.00 | 282.00M | |||
| Accrued Expenses | 51.68M | 54.00M | 58.00M | 152.00M | N/A | |||
| Accounts Payable | 15.16M | 8.00M | 6.00M | 11.00M | 11.00M | |||
| Other Current Liabilities | 94.53M | 107.00M | 108.00M | 145.00M | 40.00M | |||
| Total Current Liabilities | 161.38M | 1.17B | 171.00M | 308.00M | 333.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.14B | 6.12B | 7.10B | 5.82B | 5.96B | |||
| Other Non-Current Liabilities | 900.00K | 3.00M | N/A | 0.00 | 19.00M | |||
| Total Non-Current Liabilities | 9.69B | 10.02B | 11.57B | 10.89B | 6.01B | |||
| TOTAL LIABILITIES | 9.86B | 11.19B | 11.74B | 11.20B | 6.34B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 2.52B | 1.97B | 2.25B | 1.92B | 2.83B | |||
| Additional Paid In Capital | 4.01B | 3.67B | 3.51B | 2.87B | N/A | |||
| Minority Interest | 2.99B | 3.71B | 3.85B | 4.35B | -76.90M | |||
| Common Shares | 108.15K | 0.00 | 0.00 | 0.00 | 3.28B | |||
| Treasury Stock | -2.63M | -3.00M | -3.00M | -2.00M | -4.00M | |||
| Other Shareholders' Equity | -150.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 446.69M | 443.00M | 433.00M | 388.00M | 351.00M | |||
| Tangible Book Value per Share | 14.61 | 12.70 | 13.33 | 12.35 | 17.25 | |||
| Total Shareholders' Equity | 6.53B | 5.63B | 5.78B | 4.82B | 6.11B | |||
| TOTAL LIABILITIES AND EQUITY | 16.38B | 16.81B | 17.52B | 16.02B | 12.45B | |||
| Statistics | ||||||||
| Debt/Equity | 0.94 | 1.09 | 1.23 | 1.21 | 0.98 | |||
| Current Ratio | 7.90 | 2.19 | 16.83 | 8.76 | 2.50 | |||
| Return On Assets (ROA) | 6.93% | 0.25% | 3.54% | 3.09% | 18.86% | |||
| Return On Equity (ROE) | 17.39% | 0.76% | 10.73% | 10.28% | 38.46% | |||
| Return On Invested Capital (ROIC) | 7.27% | 4.66% | 6.52% | 8.35% | 17.10% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.87% | 5.52% | 7.77% | 10.04% | 18.30% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 7.87% | 5.52% | 7.78% | 10.06% | 18.39% | |||
All data in USD